| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Antimicrobial-resistant nocardia isolates, United States, 1995-2004.
|
Clin Infect Dis
|
2010
|
3.15
|
|
2
|
Serogroup A meningococcal conjugate vaccination in Burkina Faso: analysis of national surveillance data.
|
Lancet Infect Dis
|
2012
|
2.74
|
|
3
|
Epidemiologic and laboratory features of a large outbreak of pertussis-like illnesses associated with cocirculating Bordetella holmesii and Bordetella pertussis--Ohio, 2010-2011.
|
Clin Infect Dis
|
2012
|
2.64
|
|
4
|
Impact of the serogroup A meningococcal conjugate vaccine, MenAfriVac, on carriage and herd immunity.
|
Clin Infect Dis
|
2012
|
2.62
|
|
5
|
Association of childhood pertussis with receipt of 5 doses of pertussis vaccine by time since last vaccine dose, California, 2010.
|
JAMA
|
2012
|
2.36
|
|
6
|
Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP).
|
MMWR Recomm Rep
|
2013
|
2.20
|
|
7
|
Effectively introducing a new meningococcal A conjugate vaccine in Africa: the Burkina Faso experience.
|
Vaccine
|
2012
|
1.81
|
|
8
|
Early Impact of the US Tdap vaccination program on pertussis trends.
|
Arch Pediatr Adolesc Med
|
2012
|
1.69
|
|
9
|
Leptospirosis on Oahu: an outbreak associated with flooding of a university campus.
|
Am J Trop Med Hyg
|
2007
|
1.65
|
|
10
|
Pneumonia and septicemia caused by Burkholderia thailandensis in the United States.
|
J Clin Microbiol
|
2006
|
1.61
|
|
11
|
Waning immunity to pertussis following 5 doses of DTaP.
|
Pediatrics
|
2013
|
1.58
|
|
12
|
Candida parapsilosis characterization in an outbreak setting.
|
Emerg Infect Dis
|
2004
|
1.51
|
|
13
|
Emergence of ciprofloxacin-resistant Neisseria meningitidis in North America.
|
N Engl J Med
|
2009
|
1.48
|
|
14
|
Baseline meningococcal carriage in Burkina Faso before the introduction of a meningococcal serogroup A conjugate vaccine.
|
Clin Vaccine Immunol
|
2011
|
1.47
|
|
15
|
Prevalence and genetic diversity of candidate vaccine antigens among invasive Neisseria meningitidis isolates in the United States.
|
Vaccine
|
2011
|
1.40
|
|
16
|
Current epidemiology and trends in invasive Haemophilus influenzae disease--United States, 1989-2008.
|
Clin Infect Dis
|
2011
|
1.30
|
|
17
|
Novel Brucella strain (BO1) associated with a prosthetic breast implant infection.
|
J Clin Microbiol
|
2007
|
1.27
|
|
18
|
Pregnancy dose Tdap and postpartum cocooning to prevent infant pertussis: a decision analysis.
|
Pediatrics
|
2013
|
1.25
|
|
19
|
Epidemiologic investigation and targeted vaccination initiative in response to an outbreak of meningococcal disease among illicit drug users in Brooklyn, New York.
|
Clin Infect Dis
|
2009
|
1.25
|
|
20
|
Outbreak of leptospirosis among Adventure Race participants in Florida, 2005.
|
Clin Infect Dis
|
2010
|
1.24
|
|
21
|
The yin and yang of paracetamol and paediatric immunisations.
|
Lancet
|
2009
|
1.22
|
|
22
|
Neisseria meningitidis serogroup W, Burkina Faso, 2012.
|
Emerg Infect Dis
|
2014
|
1.22
|
|
23
|
Accuracy of real-time PCR, Gram stain and culture for Streptococcus pneumoniae, Neisseria meningitidis and Haemophilus influenzae meningitis diagnosis.
|
BMC Infect Dis
|
2013
|
1.21
|
|
24
|
Haemophilus haemolyticus isolates causing clinical disease.
|
J Clin Microbiol
|
2012
|
1.13
|
|
25
|
Patient satisfaction in the emergency department--a survey of pediatric patients and their parents.
|
Acad Emerg Med
|
2002
|
1.09
|
|
26
|
Pertussis Pseudo-outbreak linked to specimens contaminated by Bordetella pertussis DNA From clinic surfaces.
|
Pediatrics
|
2012
|
1.01
|
|
27
|
Practice patterns of infectious disease physicians for management of meningococcal disease.
|
Pediatr Infect Dis J
|
2012
|
0.99
|
|
28
|
Meningococcal disease: the organism, clinical presentation, and worldwide epidemiology.
|
J Travel Med
|
2010
|
0.95
|
|
29
|
Leptospirosis outbreak following severe flooding: a rapid assessment and mass prophylaxis campaign; Guyana, January-February 2005.
|
PLoS One
|
2012
|
0.92
|
|
30
|
SARS clinical features, United States, 2003.
|
Emerg Infect Dis
|
2005
|
0.91
|
|
31
|
Qualitative assessment of pertussis diagnostics in United States laboratories.
|
Pediatr Infect Dis J
|
2013
|
0.90
|
|
32
|
Bordetella holmesii bacteremia cases in the United States, April 2010-January 2011.
|
Clin Infect Dis
|
2013
|
0.89
|
|
33
|
Prolonged university outbreak of meningococcal disease associated with a serogroup B strain rarely seen in the United States.
|
Clin Infect Dis
|
2013
|
0.88
|
|
34
|
Diversity of factor H-binding protein in Neisseria meningitidis carriage isolates.
|
Vaccine
|
2011
|
0.85
|
|
35
|
Identifying optimal vaccination strategies for serogroup A Neisseria meningitidis conjugate vaccine in the African meningitis belt.
|
PLoS One
|
2013
|
0.84
|
|
36
|
Laboratory quality control in a multicentre meningococcal carriage study in Burkina Faso.
|
Trans R Soc Trop Med Hyg
|
2012
|
0.84
|
|
37
|
Carriage of Neisseria lactamica in 1- to 29-year-old people in Burkina Faso: epidemiology and molecular characterization.
|
J Clin Microbiol
|
2012
|
0.82
|
|
38
|
Modeling insights into Haemophilus influenzae type b disease, transmission, and vaccine programs.
|
Emerg Infect Dis
|
2012
|
0.81
|
|
39
|
Phenotypic and genotypic characterization of meningococcal carriage and disease isolates in Burkina Faso after mass vaccination with a serogroup a conjugate vaccine.
|
BMC Infect Dis
|
2013
|
0.81
|
|
40
|
Trends in Pertussis Diagnostic Testing in the United States, 1990 to 2012.
|
Pediatr Infect Dis J
|
2016
|
0.81
|
|
41
|
Responding to pertussis.
|
J Pediatr
|
2012
|
0.77
|
|
42
|
Use of MenACWY-CRM vaccine in children aged 2 through 23 months at increased risk for meningococcal disease: recommendations of the Advisory Committee on Immunization Practices, 2013.
|
MMWR Morb Mortal Wkly Rep
|
2014
|
0.75
|
|
43
|
Haemophilus influenzae type b disease and vaccine booster dose deferral, United States, 1998-2009.
|
Pediatrics
|
2012
|
0.75
|
|
44
|
Estimating the effectiveness of acellular pertussis vaccines.
|
Clin Infect Dis
|
2012
|
0.75
|
|
45
|
MCV vaccination in the presence of vaccine-associated Guillain-Barré Syndrome risk: a decision analysis approach.
|
Vaccine
|
2009
|
0.75
|
|
46
|
Brucellosis seroprevalence among workers in at-risk professions: northwestern Wyoming, 2005 to 2006.
|
J Occup Environ Med
|
2012
|
0.75
|
|
47
|
Rapid Laboratory Identification of Neisseria meningitidis Serogroup C as the Cause of an Outbreak - Liberia, 2017.
|
MMWR Morb Mortal Wkly Rep
|
2017
|
0.75
|
|
48
|
Safety assessment of recalled Haemophilus influenzae type b (Hib) conjugate vaccines--United States, 2007-2008.
|
Pharmacoepidemiol Drug Saf
|
2010
|
0.75
|